Atul Sharan founded CellMax Life while an Entrepreneur-in-Residence at Artiman Ventures. Prior to CellMax, Atul was President and CEO at AutoESL (acquired by Xilinx), Founder, President and CEO at Clear Shape Technologies (acquired by Cadence), and held a variety of senior leadership positions in the EDA field. Atul has an M.B.A. from UC-Berkeley in Finance & Management, an M.S. in Engineering from the University of Houston and a B.S. in Engineering from IIT, Kanpur.
CellMax Life, Inc. is a precision cancer blood-testing company providing comprehensive, personalized multi-biomarker technology platforms for genetic cancer risk assessment, early detection and personalized treatment of cancer.
Colorectal Cancer Diagnosis
Cancer Risk Assessment